Search Results - "VANNICE, J. L"

Refine Results
  1. 1

    Different Receptor Mechanisms Mediate the Pyrogenic and Behavioral Effects of Interleukin 1 by Kent, Stephen, Bluthe, Rose-Marie, Dantzer, Robert, Hardwick, Anthea J., Kelley, Keith W., Rothwell, Nancy J., Vannice, James L.

    “…Interleukin 1 (IL-1) is a cytokine released during immune activation that mediates the host's response to infection and inflammation. Peripheral and central…”
    Get full text
    Journal Article
  2. 2

    Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats by KIMBLE, R. B, VANNICE, J. L, BLOEDOW, D. C, THOMPSON, R. C, HOPFER, W, KUNG, V. T, BROWNFIELD, C, PACIFICI, R

    Published in The Journal of clinical investigation (01-05-1994)
    “…Interleukin-1 (IL-1), a cytokine produced by bone marrow cells and bone cells, has been implicated in the pathogenesis of postmenopausal osteoporosis because…”
    Get full text
    Journal Article
  3. 3

    Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice by Kitazawa, R, Kimble, R B, Vannice, J L, Kung, V T, Pacifici, R

    Published in The Journal of clinical investigation (01-12-1994)
    “…To investigate the contribution of IL-1, IL-6, and TNF to the increased osteoclastogenesis induced by estrogen deficiency, ovariectomized (ovx) mice were…”
    Get full text
    Journal Article
  4. 4

    A Second Tumor Necrosis Factor Receptor Gene Product can Shed a Naturally Occurring Tumor Necrosis Factor Inhibitor by Kohno, Tadahiko, Brewer, Michael T., Baker, Susan L., Schwartz, Phillip E., King, Michael W., Hale, Karin K., Squires, Charles H., Thompson, Robert C., Vannice, James L.

    “…An inhibitor of tumor necrosis factor (TNF) has been isolated from the human histiocytic lymphoma cell line U-937 that is capable of inhibiting both TNF-α and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis by TANG, W. W, LILI FENG, VANNICE, J. L, WILSON, C. B

    “…The contribution of IL-1 to leukocyte infiltration in anti-glomerular basement membrane (GBM) antibody (Ab) glomerulonephritis (GN) was examined by the…”
    Get full text
    Journal Article
  7. 7

    Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist by Lan, Hui Y., Nikolic-Paterson, David J., Zarama, Mario, Vannice, James L., Atkins, Robert C.

    Published in Kidney international (01-02-1993)
    “…Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. The role of interleukin-1 (IL-1) in the pathogenesis of…”
    Get full text
    Journal Article
  8. 8

    Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients by Parsons, P E, Moss, M, Vannice, J L, Moore, E E, Moore, F A, Repine, J E

    “…Although numerous cytokines, including interleukin (IL)-1, IL-8, and tumor necrosis factor, circulate in critically ill patients at risk for acute respiratory…”
    Get more information
    Journal Article
  9. 9

    Purification, Cloning, and Expression of Ciliary Neurotrophic Factor (CNTF) by Lin, Leu-Fen H., Mismer, Drzislav, Lile, Jack D., Armes, Lyman G., Butler, Eugene T., Vannice, James L., Collins, Frank

    “…Ciliary neurotrophic factor (CNTF) is one of a small number of proteins with neurotrophic activities distinct from nerve growth factor (NGF). CNTF has now been…”
    Get full text
    Journal Article
  10. 10

    Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat by Lan, Hui Y., Nikolic-Paterson, David J., Mu, Wei, Vannice, James L., Atkins, Robert C.

    Published in Kidney international (01-05-1995)
    “…Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. The pathogenic role of interleukin-1 (IL-1) in…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy by Pacifici, R, Vannice, J L, Rifas, L, Kimble, R B

    “…Interleukin-1 (IL-1), a potent stimulant of bone resorption, has been implicated in the pathogenesis of postmenopausal osteoporosis, because monocyte IL-1…”
    Get more information
    Journal Article
  12. 12

    The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence by JAKOBOVITS, E. B, SCHLOKAT, U, VANNICE, J. L, DERYNCK, R, LEVINSON, A. D

    Published in Molecular and Cellular Biology (01-12-1988)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  13. 13

    Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice by Vallera, D A, Taylor, P A, Vannice, J L, Panoskaltsis-Mortari, A, Blazar, B R

    Published in Transplantation (15-12-1995)
    “…We show that while interleukin-1 and tumor necrosis factor-alpha antagonists are partially able to inhibit graft-versus-host disease (GVHD) when bone marrow…”
    Get more information
    Journal Article
  14. 14

    Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss by Kimble, R B, Kitazawa, R, Vannice, J L, Pacifici, R

    Published in Calcified tissue international (01-10-1994)
    “…The recent finding that treatment with the interleukin-1 (IL-1) inhibitor, interleukin-1 receptor antagonist (IL-1ra) decreases bone loss and bone resorption…”
    Get full text
    Journal Article
  15. 15

    Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity by VANNICE, J. L, LEVINSON, A. D

    Published in Journal of Virology (01-04-1988)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Inhibition of protein synthesis stimulates the transcription of human beta-interferon genes in Chinese hamster ovary cells by Ringold, G M, Dieckmann, B, Vannice, J L, Trahey, M, McCormick, F

    “…Using Chinese hamster ovary (CHO) cells transfected with a plasmid carrying the human beta-interferon gene, we find that inhibitors of protein synthesis, in…”
    Get full text
    Journal Article
  17. 17

    Glucocorticoid-mediated induction of alpha 1-acid glycoprotein: evidence for hormone-regulated RNA processing by Vannice, J L, Taylor, J M, Ringold, G M

    “…We have studied the glucocorticoid-mediated accumulation of alpha 1-acid glycoprotein (AGP) in mRNA in HTC rat hepatoma cells. In contrast to the…”
    Get full text
    Journal Article
  18. 18

    The Inhibitor Cytokine Interleukin-1 Receptor Antagonist Synergistically Augments Cyclosporine Immunosuppression in a Rat Cardiac Allograft Model by Shiraishi, Masayuki, Csete, Marie, Yasunaga, Chikao, McDiarmid, Sue V., Vannice, James L., Busuttil, Ronald W., Shaked, Abraham

    Published in The Journal of surgical research (01-05-1995)
    “…Interleukin-1 receptor antagonist (IL-Ira) competes with IL-1 for binding of the IL-1 receptor, but does not elicit a cellular immune response. This study was…”
    Get full text
    Journal Article
  19. 19

    Post-insult treatment with interleukin-1 receptor antagonist decreases oxidative lung injury in rats given intratracheal interleukin-1 by Leff, J A, Bodman, M E, Cho, O J, Rohrbach, S, Reiss, O K, Vannice, J L, Repine, J E

    “…Systemic administration of recombinant human interleukin-1 receptor antagonist (IL-1Ra) caused a rapid and sustained elevation of plasma IL-1Ra levels and…”
    Get more information
    Journal Article
  20. 20

    Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period by Kimble, R B, Matayoshi, A B, Vannice, J L, Kung, V T, Williams, C, Pacifici, R

    Published in Endocrinology (Philadelphia) (01-07-1995)
    “…Considerable evidence supports the hypothesis that estrogen prevents bone loss by blocking the production of cytokines in bone or bone marrow. However,…”
    Get more information
    Journal Article